Trends in microdosing and other exploratory human pharmacokinetic studies for early drug development.
Bioanalysis March 1, 2010 DOI: 10.4155/bio.10.11 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Microdosing |
| Key findings | Argues that microdosing and exploratory pharmacokinetic studies are increasingly valuable in early drug development for obtaining human disposition data, which can inform candidate selection and reduce late-stage failures. |
Abstract
Trends in microdosing and other exploratory human pharmacokinetic studies for early drug development.
Comparable studies
Other narrative reviews on microdosing, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Big physics, small doses: the use of AMS and PET in human microdosing of development drugs | 2003 | Review | |
| Phase 0/microdosing approaches: time for mainstream application in drug development? | 2020 | Review | |
| Microdosing and drug development: past, present and future | 2013 | Review | |
| Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development | 2016 | Review | |
| Expectancy Effects in Psychedelic Trials. | 2024 | Review |